# US 2005/0049201 A1 · Detection and removal of lead using lead-binding proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0049201 A1
- Document ID: US20050049201A1
- Status: Published application
- Kind: A1
- Application number: 10/498,292
- Filed: 2002-12-11
- Published: 2005-03-03
- Earliest claimed: 2001-12-11
- Inventors: Adrian Lowe; Gerard Colpas; Maureen Hamilton; Michael Salcius; Mitchell Sanders
- Web page: https://patentgrep.com/patent/US20050049201A1

## CPC

- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/47: from mammals
- C07K 14/57581: {Thymosin; Related peptides}
- G01N 33/84: involving inorganic compounds or pH
- G01N 2333/5759: Thymosin or related peptides
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Thymosin beta-4 (TB4), Thymosin beta-9 (TB9), and acyl-CoA binding protein (ACBP) are two proteins that possess the ability to bind lead in human tissue. These two proteins have a high affinity lead-binding region with a dissociation constant (Kd) of about 10−9 M that allows for a strong interaction between the metal and the protein. These proteins and their analogs and lead-binding fragments can be used to detect and remove lead from various media.

## Claims

### Claim 1

A lead-binding polypeptide comprising the motif EX1X2E-liner-EX3X4E, wherein each of X1, X2, X3, and X4 are residues capable of forming an alpha helix, and wherein the linker contains a turn motif.

### Claim 2 (depends on 1)

The lead-binding polypeptide of claim 1, wherein said polypeptide consists of the sequence of SEQ ID NO: 10.

### Claim 3

A device for detecting and/or removing lead in a sample, comprising a matrix to which is affixed one or more lead-binding proteins, wherein said one or more lead-binding proteins comprises a polypeptide having the motif EX1X2E-linker-EX3X4E, wherein each of X1, X2, X3, and X4 are residues capable of forming an alpha helix, and wherein the linker contains a turn motif.

### Claim 4

A device for detecting and/or removing lead in a sample, comprising a matrix to which is affixed one or more lead-binding proteins, wherein said one or more lead-binding proteins comprises a polypeptide selected from the group consisting of acyl-CoA binding protein, thymosin beta-4, and thymosin beta-9, or lead-binding fragments or variants thereof.

### Claim 5 (depends on 4)

The device of claim 4, wherein said thymosin beta-4 protein comprises the sequence of SEQ ID NO: 1 or SEQ ID NO: 10.

### Claim 6 (depends on 4)

The device of claim 4, wherein said acyl-CoA binding protein comprises the sequence of SEQ ID NO: 2.

### Claim 7 (depends on 4)

The device of claim 4, wherein said thymosin beta-9 protein comprises the sequence of SEQ ID NO: 9.

### Claim 8 (depends on 4)

The device of claim 4, wherein said one or more lead-binding proteins is detectably labeled.

### Claim 9 (depends on 8)

The device of claim 8, wherein said label comprises a fluorescent label.

### Claim 10

A method for detecting the presence of lead in a sample, comprising:
a) contacting the sample with one or more lead-binding proteins under conditions sufficient for lead in the sample to bind to the lead-binding protein, wherein said one or more lead-binding proteins comprises a polypeptide selected from the group consisting of acyl-CoA binding protein, thymosin beta-4, and thymosin beta-9, or lead-binding fragments or variants thereof; and
b) detecting the presence of lead in said sample.

### Claim 11 (depends on 10)

The method of claim 10, wherein said thymosin beta-4 protein comprises the sequence of SEQ ID NO: 1 or SEQ ID NO: 10.

### Claim 12 (depends on 10)

The method of claim 10, wherein said acyl-CoA binding protein comprises the sequence of SEQ ID NO: 2.

### Claim 13 (depends on 10)

The method of claim 10, wherein said thymosin beta-9 protein comprises the sequence of SEQ ID NO: 9.

### Claim 14 (depends on 10)

The method of claim 10, wherein said one or more lead-binding proteins or lead-binding fragments or variants thereof are labeled with a detectable label, and wherein detection occurs by detecting an alteration of said detectable label.

### Claim 15

A method for detecting the presence of lead in a sample, comprising:
a) contacting the sample with one or more detectably labeled lead-binding proteins under conditions sufficient for binding of lead to said lead-binding protein, wherein said one or more lead-binding proteins are attached to a solid substrate, and wherein said one or more lead-binding proteins comprises a polypeptide selected from the group consisting of acyl-CoA binding protein, thymosin beta-4, and thymosin beta-9, or lead-binding fragments or variants thereof, and
b) detecting the presence of lead in the sample by detecting said detectable label.

### Claim 16 (depends on 15)

The method of claim 15, wherein detecting the presence of lead in said sample comprises contacting said lead-binding protein or lead-binding fragments or variants thereof with a detectable label that differentiates between lead-binding proteins or lead-binding fragments or variants thereof that are bound with lead, and those that are not;
and wherein detection occurs by detecting an alteration of said detectable label.

### Claim 17 (depends on 15)

The method of claim 15, wherein said solid substrate comprises a matrix.

### Claim 18 (depends on 15)

The method of claim 15, wherein said thymosin beta-4 protein comprises the sequence of SEQ D NO: 1 or SEQ ID NO: 10.

### Claim 19 (depends on 15)

The method of claim 15, wherein said acyl-CoA binding protein comprises the sequence of SEQ DD NO: 2.

### Claim 20 (depends on 15)

The method of claim 15, wherein said thymosin beta-9 protein comprises the sequence of SEQ ID NO: 9.

### Claim 21

A method for removing lead from a sample, comprising contacting said sample with one or more lead-binding proteins affixed to a matrix, wherein said one or more lead-binding proteins comprises a polypeptide selected from the group consisting of acyl-CoA binding protein, thymosin beta-4, and thymosin beta-9, or lead-biding fragments or variants thereof; wherein lead in said sample binds to said binding protein, whereby lead is removed from said sample.

### Claim 22 (depends on 21)

The method of claim 21, wherein said thymosin beta-4 protein comprises the sequence of SEQ ED NO: 1 or SEQ ID NO: 10.

### Claim 23 (depends on 21)

The method of claim 21, wherein said acyl-CoA binding protein comprises the sequence of SEQ ID NO: 2.

### Claim 24 (depends on 21)

The method of claim 21, wherein said thymosin beta-9 protein comprises the sequence of SEQ ID NO: 9.

### Claim 25

A device for detecting the presence of lead in a sample, said device comprising:
a) a solid substrate having attached thereto a matrix;
b) a matrix comprising a ligand, wherein said ligand is diffusable through said matrix and detectable, wherein said ligand specifically binds to lead, and wherein said ligand is localized to a specific area of said matrix; and
c) one or more lead-binding proteins immobilized in said matrix and localized to a specific area of said matrix different from said ligand, wherein said one or more lead-binding proteins comprises a polypeptide selected from the group consisting of acyl-CoA binding protein, thymosin beta-4, and thymosin beta-9, or lead-binding fragments or variants thereof.

### Claim 26 (depends on 25)

The device of claim 25, wherein said ligand comprises a chromogen.

### Claim 27 (depends on 25)

The device of claim 25, wherein said thymosin beta-4 protein comprises the sequence of SEQ ID NO: 1 or SEQ ID NO: 10.

### Claim 28 (depends on 25)

The device of claim 25, wherein said acyl-CoA binding protein comprises the sequence of SEQ ID NO: 2.

### Claim 29 (depends on 25)

The device of claim 25, wherein said thymosin beta-9 protein comprises the sequence of SEQ ID NO: 9.

### Claim 30 (depends on 25)

The device of claim 25, wherein said area of said matrix containing the ligand and said area of the matrix comprising one or more lead-binding proteins, or lead-binding fragments or variants thereof, are located at opposite ends of said device, separated by matrix that does not contain ligand or protein.

### Claim 31 (depends on 22)

A method of detecting the presence of lead in a sample, comprising:
a) contacting the sample with the device of claim 22, wherein the sample contacts the area comprising the ligand under conditions suitable for the lead ill the sample to bind to the ligand;
b) maintaining the device under conditions wherein the lead bound ligand diffuses to the area comprising the lead-binding protein, wherein the lead bound ligand binds to the protein and is thereby immobilized: and
c) detecting the immobilized lead.

### Claim 32 (depends on 31)

The method of claim 31, wherein said thymosin beta-4 protein comprises the sequence of SEQ ID NO: 1 or SEQ ID NO: 10.

### Claim 33 (depends on 31)

The method of claim 31, wherein said acyl-CoA binding protein comprises the sequence of SEQ ID NO: 2.

### Claim 34 (depends on 31)

The method of claim 31, wherein said thymosin beta-9 protein comprises the sequence of SEQ ED NO: 9.

### Claim 35 (depends on 31)

The method of claim 31, wherein said ligand comprises a chromogen.

### Claim 36 (depends on 25)

A Lit for detection of lead in a sample, said kit comprising the device of claim 25 and one or more reagents for detecting lead in a sample.

### Claim 37 (depends on 4)

A kit for removing, lead from a sample, said kit comprising the device of claim 4 and instructions for use of said device.

### Claim 38 (depends on 37)

The kit of claim 37, wherein said matrix comprises an absorbent material.
